Maravai (MRVI) Price to Earnings Ratio

Corporate emblem and logo of Maravai LifeSciences Corp (MRVI)

The P/E ratio for Maravai LifeSciences (MRVI) demonstrates the stability of B2B relationships within the mRNA sector, where strict FDA regulations guarantee customer loyalty. Management is betting on nucleic acid synthesis to maintain high profitability. However, reductions in R&D budgets and a post-pandemic decline in demand create risks for margins. The current value of the parameter is -17.10, which allows for an objective assessment of the asset's payback period.

MRVI Maravai LifeSciences Holdings, Inc.: Price to Earnings Ratio in the range 07/04/2022 - 11/17/2026

Analytical breakdowns for Maravai LifeSciences

Comprehensive company analysis:MRVI Maravai LifeSciences Holdings, Inc.
Manufactured product of Maravai LifeSciences

The humanitarian status of Maravai LifeSciences (MRVI) shipments minimizes geopolitical risks, creating a stable cash flow that the market values based on the cost per unit of net profit. By analyzing the P/E ratio trend, an investor determines the degree of market optimism or asset overvaluation, as ignoring inflated multiples leads to capital losses, while unfounded fear of low values forfeits potential income.

Key competitors

Agilent (A) - Business Payback Period|Price to Earnings Ratio DGX (questdiagnostics.com)|Price to Earnings Ratio ILMN (Illumina, Inc.)|Exact Sciences Corp - Price to Earnings Ratio|revvity.com (RVTY) - Market Cap to Earnings|Bio-Rad Laboratories, Inc. - P/E Multiple|Business Payback Period Anbio NNNN|Nordion (SHC) - Price to Earnings Ratio|QDEL - Business Payback Period|Price to Earnings Ratio OPKO Health Inc|CareDx (CDNA) - Business Payback Period|P/E Multiple FLGT|Market Price to Net Income Ratio LAB|cytekbio.com - Price to Earnings Ratio|Company Value to Net Income OSUR|exagen.com - P/E Multiple|MDXH (MDxHealth SA) - Price to Earnings Multiple|LUCD: P/E Multiple|Market Cap to Earnings Prenetics Global (PRE)|IMDX (Insight Molecular Diagnostics) - P/E Multiple|Trinity Biotech (TRIB) - Business Payback Period|P/E Multiple PRPH|AIMD (Ainos, Inc.) - Company Value to Net Income|P/E Multiple CODX (codiagnostics.com)|Market Price to Net Income Ratio HSCS (HeartSciences)|Biomerica Inc - P/E Multiple|CDIO (cardiodiagnosticsinc.com) - Price to Earnings Multiple|ONCO (Onconetix) - Price to Earnings Ratio|Market Cap to Earnings viraxbiolabs.com (VRAX)|BJDX (Bluejay Diagnostics Inc) - P/E Multiple|Market Cap to Earnings Aspira Women's Health, Inc. AWH|Price to Earnings Ratio AXDX (Accelerate Diagnostics, Inc)|CENTOGENE, N.V. - Price to Earnings Multiple|Enzo Biochem, Inc. - Price to Earnings Ratio|FRES - Price to Earnings Ratio|GENE - Price to Earnings Ratio|Company Value to Net Income ME (23andMe)|PMD: P/E Multiple